317 related articles for article (PubMed ID: 19828468)
1. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
[TBL] [Abstract][Full Text] [Related]
2. Antisense phosphorothioate oligodeoxynucleic acid for CD10 suppresses liver metastasis of colorectal cancer.
Luo Y; Fujii K; Ohmori H; Sasahira T; Moriwaka Y; Isobe M; Kuniyasu H
Pathobiology; 2009; 76(5):267-73. PubMed ID: 19816087
[TBL] [Abstract][Full Text] [Related]
3. Methionine-enkephalin secreted by human colorectal cancer cells suppresses T lymphocytes.
Ohmori H; Fujii K; Sasahira T; Luo Y; Isobe M; Tatsumoto N; Kuniyasu H
Cancer Sci; 2009 Mar; 100(3):497-502. PubMed ID: 19141128
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 attenuates anti-metastatic defence of the liver in colorectal cancer.
Luo Y; Ohmori H; Fujii K; Moriwaka Y; Sasahira T; Kurihara M; Tatsumoto N; Sasaki T; Yamashita Y; Kuniyasu H
Eur J Cancer; 2010 Mar; 46(4):791-9. PubMed ID: 20018503
[TBL] [Abstract][Full Text] [Related]
5. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
6. LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis.
Hsu RY; Chan CH; Spicer JD; Rousseau MC; Giannias B; Rousseau S; Ferri LE
Cancer Res; 2011 Mar; 71(5):1989-98. PubMed ID: 21363926
[TBL] [Abstract][Full Text] [Related]
7. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of risk of liver metastasis in colorectal adenocarcinoma based on the combination of risk factors including CD10 expression: multivariate analysis of clinicopathological and immunohistochemical factors.
Ohji Y; Yao T; Eguchi T; Yamada T; Hirahashi M; Iida M; Tsuneyoshi M
Oncol Rep; 2007 Mar; 17(3):525-30. PubMed ID: 17273728
[TBL] [Abstract][Full Text] [Related]
9. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
11. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer.
Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS
Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165
[TBL] [Abstract][Full Text] [Related]
12. mTOR signaling pathway is a target for the treatment of colorectal cancer.
Zhang YJ; Dai Q; Sun DF; Xiong H; Tian XQ; Gao FH; Xu MH; Chen GQ; Han ZG; Fang JY
Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
[TBL] [Abstract][Full Text] [Related]
13. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.
Attoub S; Rivat C; Rodrigues S; Van Bocxlaer S; Bedin M; Bruyneel E; Louvet C; Kornprobst M; André T; Mareel M; Mester J; Gespach C
Cancer Res; 2002 Sep; 62(17):4879-83. PubMed ID: 12208734
[TBL] [Abstract][Full Text] [Related]
14. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
15. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
[TBL] [Abstract][Full Text] [Related]
16. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
[TBL] [Abstract][Full Text] [Related]
18. Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers.
Miyamoto S; Nakamura M; Shitara K; Nakamura K; Ohki Y; Ishii G; Goya M; Kodama K; Sangai T; Maeda H; Shi-Chuang Z; Chiba T; Ochiai A
Clin Cancer Res; 2005 May; 11(9):3494-502. PubMed ID: 15867252
[TBL] [Abstract][Full Text] [Related]
19. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
Man K; Ng KT; Xu A; Cheng Q; Lo CM; Xiao JW; Sun BS; Lim ZX; Cheung JS; Wu EX; Sun CK; Poon RT; Fan ST
Clin Cancer Res; 2010 Feb; 16(3):967-77. PubMed ID: 20103676
[TBL] [Abstract][Full Text] [Related]
20. Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
Yang L; Huang Y; Porta R; Yanagisawa K; Gonzalez A; Segi E; Johnson DH; Narumiya S; Carbone DP
Cancer Res; 2006 Oct; 66(19):9665-72. PubMed ID: 17018624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
